Vol. 9 No. 3 (2013): May/June

Published: 05/01/2013

Articles

Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States

Carl L. Roland, PharmD, Ashish V. Joshi, PhD, Jack Mardekian, PhD, Steven C. Walden, PharmD, MBA, James Harnett, PharmD, MS

161—175
- Requires Subscription or Fee PDF (USD 56)
Usefulness of the opioid risk tool to predict aberrant drug-related behavior in patients receiving opioids for the treatment of chronic pain

Lisa R. Witkin, MD, Dina Diskina, BS, Shawn Fernandes, BS, John T. Farrar, MD, PhD, Michael A. Ashburn, MD, MPH

177—187
- Requires Subscription or Fee PDF (USD 56)
Rationale and design of the Oxycodone Users Registry: A prospective, multicenter registry of patients with nonmalignant pain

Myoung Kim, PhD, Wing Chow, PharmD, MPH, Carmela Benson, MS

189—196
- Requires Subscription or Fee PDF (USD 56)
Gastrointestinal events after opioid treatment in nonmalignant pain: Correlates of occurrence and impact on health-related quality of life

Kate L. Lapane, PhD, Brian J. Quilliam, PhD, Carmela Benson, MS, Wing Chow, PharmD, MPH, Myoung S. Kim, PhD, MBA

205—216
- Requires Subscription or Fee PDF (USD 56)
Opioid prescribing knowledge and practices: Provider survey following promulgation of guidelines–Utah, 2011

Christina A. Porucznik, PhD, MSPH, Erin M. Johnson, MPH, Robert T. Rolfs, MD, MPH, Brian C. Sauer, PhD

217—224
- Requires Subscription or Fee PDF (USD 56)

Case Studies

Undetected Ultracet™ dependence in an adolescent with nonmalignant back pain

Nabil A. Khan, BA, Maria A. Sullivan, MD, PhD, Michael G. Vitale, MD, MPH, Mary Ellen Tresgallo, DNP, MPH, MS, John M. Saroyan, MD

225—230
- Requires Subscription or Fee PDF (USD 56)